PRINCETON, N.J., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Orchid Cellmark Inc. (Nasdaq:ORCH), a leading international provider of identity DNA testing services, today announced it has granted a worldwide license to Illumina, Inc. for the commercial development of Orchid’s proprietary single base nucleotide extension technology for the diagnostic and forensic fields.
